The other four are also highly relevant for liver disease: APOE (apolipoprotein E), dipeptidyl peptidase‐4 (DPP4), TGFBI (transforming growth factor‐beta‐induced protein ig‐h3), and aminopeptidase N (ANPEP). This evidence concerns the gene TGFBI and liver disorder.